I don't want to be a killjoy bitch, but all the normal procedures to elaborate a vaccine were super rushed so even if for now tests seem to indicate a possible positive effect it's not inconceivable that a few months from now we'll see huge side effects we hadn't predicted, which would stop the commercialization of the stuff.
What I mean is let's follow this closely but not rejoice too fast.
While that's possible I think the main difficulty will be the transport and storage since the Pfizer vaccine requires a temperature of -80°C (-112°F).
2
deleted
· 3 years ago
No, absolutely nothing was rushed nor the quality of the control was lesser. It's just that usually the people that need to approve the vaccines receive all the data in one big bulk that needs months to be reviewed and approved but due to the circonstances instead of sending one big bulk they sent all the data that they got as they came so it could go as smooth as possible and have no delay. Since the company that is developing the vaccine is in Germany, there's no way that anything that is not the norm would have gone through.
Also this is the BioNTech Vaccine, not Pfizer. They researched and developed the vaccine, Pfizer only helped for upscale testing. So that's nice to give credit where it's due
But the tests usually run for a few months so "sneaky" side effect can be noticed, which hasn't been the case it seems.
Granted I'm not a specialist, I just read the special edition of Science et Vie dedicated to possible vaccines. I trust them to be well informed and impartial but once again I'm not a specialist.
What I mean is let's follow this closely but not rejoice too fast.
Also this is the BioNTech Vaccine, not Pfizer. They researched and developed the vaccine, Pfizer only helped for upscale testing. So that's nice to give credit where it's due
Granted I'm not a specialist, I just read the special edition of Science et Vie dedicated to possible vaccines. I trust them to be well informed and impartial but once again I'm not a specialist.